Merck heart failure drug misses goals in study - Reuters
![]() CTV.ca | Merck heart failure drug misses goals in study Reuters NEW YORK (Reuters) - Merck & Co Inc's (MRK.N) experimental heart failure drug, one of the drugmaker's important potential medicines, failed to meet the goals of a pivotal late-stage study, the company said on Friday. Merck Won't Seek Approval for Heart-Failure Drug This Year Merck's heart failure drug misses trial goals |



del.icio.us
Digg


Post your comment